Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 70
Filtrar
Más filtros

País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Lancet ; 400(10362): 1513-1521, 2022 10 29.
Artículo en Inglés | MEDLINE | ID: mdl-36522207

RESUMEN

BACKGROUND: Internationally, a single standard chemotherapy treatment for Ewing sarcoma is not defined. Because different chemotherapy regimens were standard in Europe and the USA for newly diagnosed Ewing sarcoma, and in the absence of novel agents to investigate, we aimed to compare these two strategies. METHODS: EURO EWING 2012 was a European investigator-initiated, open-label, randomised, controlled phase 3 trial done in 10 countries. We included patients aged 2-49 years, with any histologically and genetically confirmed Ewing sarcoma of bone or soft tissue, or Ewing-like sarcomas. The eligibility criteria originally excluded patients with extrapulmonary metastatic disease, but this was amended in the protocol (version 3.0) in September, 2016. Patients were randomly assigned (1:1) to either the European regimen of vincristine, ifosfamide, doxorubicin, and etoposide induction, and consolidation using vincristine, actinomycin D, with ifosfamide or cyclophosphamide, or busulfan and melphalan (group 1); or the US regimen of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide induction, plus ifosfamide and etoposide, and consolidation using vincristine and cyclophosphamide, or vincristine, actinomycin D, and ifosfamide, with busulfan and melphalan (group 2). All drugs were administered intravenously. The primary outcome measure was event-free survival. We used a Bayesian approach for the design, analysis, and interpretation of the results. Patients who received at least one dose of study treatment were considered in the safety analysis. The trial was registered with EudraCT, 2012-002107-17, and ISRCTN, 54540667. FINDINGS: Between March 21, 2014, and May 1, 2019, 640 patients were entered into EE2012, 320 (50%) randomly allocated to each group. Median follow-up of surviving patients was 47 months (range 0-84). Event-free survival at 3 years was 61% with group 1 and 67% with group 2 (adjusted hazard ratio [HR] 0·71 [95% credible interval 0·55-0·92 in favour of group 1). The probability that the true HR was less than 1·0 was greater than 0·99. Febrile neutropenia as a grade 3-5 treatment toxicity occurred in 234 (74%) patients in group 1 and in 183 (58%) patients in group 2. More patients in group 1 (n=205 [64%]) required at least one platelet transfusion compared with those in group 2 (n=138 [43%]). Conversely, more patients required blood transfusions in group 2 (n=286 [89%]) than in group 1 (n=277 [87%]). INTERPRETATION: Dose-intensive chemotherapy with vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide is more effective, less toxic, and shorter in duration for all stages of newly diagnosed Ewing sarcoma than vincristine, ifosfamide, doxorubicin, and etoposide induction and should now be the standard of care for Ewing sarcoma. FUNDING: The European Union's Seventh Framework Programme for Research, Technological Development, and Demonstration; The National Coordinating Centre in France, Centre Léon Bérard; SFCE; Ligue contre le cancer; Cancer Research UK.


Asunto(s)
Neoplasias Óseas , Sarcoma de Ewing , Humanos , Sarcoma de Ewing/tratamiento farmacológico , Sarcoma de Ewing/etiología , Sarcoma de Ewing/patología , Ifosfamida/efectos adversos , Etopósido , Vincristina , Dactinomicina/efectos adversos , Busulfano/uso terapéutico , Melfalán/efectos adversos , Teorema de Bayes , Neoplasias Óseas/tratamiento farmacológico , Neoplasias Óseas/secundario , Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos , Ciclofosfamida , Doxorrubicina , Supervivencia sin Enfermedad
2.
Eur J Immunol ; 51(5): 1182-1194, 2021 05.
Artículo en Inglés | MEDLINE | ID: mdl-33521935

RESUMEN

Stringent regulation of the inflammatory response is crucial for normal tissue regeneration. Here, we analyzed the role of Toll-like receptor 3 (TLR3) in pancreatic regeneration after acute pancreatitis (AP). AP was induced by caerulein treatment in mice with global TLR3 deficiency (TLR3OFF ) or in mice re-expressing TLR3 exclusively in the myeloid cell lineage (TLR3Mye ). Compared to WT mice, TLR3OFF mice had a markedly increased formation of acinar-to-ductal metaplasia (ADM) that persisted until day 7 after initiation of AP. Pancreatic tissue of WT mice was completely regenerated after 5 days with no detectable ADM structures. The enhancing effect of TLR3-deficiency on ADM formation was closely linked with an increased and prolonged accumulation of macrophages in pancreata of TLR3OFF mice. Importantly, the phenotype of TLR3OFF mice was rescued in TLR3Mye mice, demonstrating the causative role of myeloid cell selective TLR3 signaling. Moreover, in vitro stimulation of macrophages through TLR3 initiated cell death by a caspase-8-associated mechanism. Therefore, these findings provide evidence that TLR3 signaling in myeloid cells is sufficient to limit inflammation and ADM formation and to promote regeneration after AP. Notably, resolution of inflammation after AP was associated with macrophage sensitivity to TLR3-mediated cell death.


Asunto(s)
Expresión Génica , Células Mieloides/metabolismo , Pancreatitis/genética , Pancreatitis/metabolismo , Receptor Toll-Like 3/genética , Enfermedad Aguda , Animales , Biomarcadores , Proliferación Celular , Citocinas/metabolismo , Modelos Animales de Enfermedad , Inmunohistoquímica , Macrófagos/inmunología , Macrófagos/metabolismo , Ratones , Ratones Noqueados , Células Mieloides/inmunología , Pancreatitis/inmunología , Pancreatitis/patología , Regeneración/genética , Transducción de Señal , Receptor Toll-Like 3/metabolismo
3.
Br J Clin Pharmacol ; 88(9): 4220-4223, 2022 09.
Artículo en Inglés | MEDLINE | ID: mdl-35491467

RESUMEN

It is not clear if platelet responses are sustained after thrombopoietin receptor agonist (ar-TPO) withdrawal in paediatric patients. A multicentre retrospective observational study was performed in children with chronic immune thrombopenia (cITP) to describe ar-TPO tapering and withdrawal in patients who had achieved a sustained complete response to ar-TPOs. Ten patients (eltrombopag n = 6, romiplostim n = 4) were included. Treatment withdrawal was performed after a mean tapering time of 7.6 months. Two patients relapsed (median follow-up time of 24 months). Slow tapering and withdrawal of ar-TPOs can be safely performed in cITP paediatric patients after achieving a sustained complete response.


Asunto(s)
Fármacos Hematológicos , Púrpura Trombocitopénica Idiopática , Receptores de Trombopoyetina , Benzoatos/uso terapéutico , Plaquetas , Niño , Fármacos Hematológicos/uso terapéutico , Humanos , Hidrazinas/uso terapéutico , Recuento de Plaquetas , Púrpura Trombocitopénica Idiopática/tratamiento farmacológico , Pirazoles/uso terapéutico , Receptores Fc/uso terapéutico , Receptores de Trombopoyetina/agonistas , Proteínas Recombinantes de Fusión/uso terapéutico , Trombopoyetina/uso terapéutico
4.
Int J Mol Sci ; 23(15)2022 08 04.
Artículo en Inglés | MEDLINE | ID: mdl-35955799

RESUMEN

Endoglin (ENG) is a mesenchymal stem cell (MSC) marker typically expressed by active endothelium. This transmembrane glycoprotein is shed by matrix metalloproteinase 14 (MMP14). Our previous work demonstrated potent preclinical activity of first-in-class anti-ENG antibody-drug conjugates as a nascent strategy to eradicate Ewing sarcoma (ES), a devastating rare bone/soft tissue cancer with a putative MSC origin. We also defined a correlation between ENG and MMP14 expression in ES. Herein, we show that ENG expression is significantly associated with a dismal prognosis in a large cohort of ES patients. Moreover, both ENG/MMP14 are frequently expressed in primary ES tumors and metastasis. To deepen in their functional relevance in ES, we conducted transcriptomic and proteomic profiling of in vitro ES models that unveiled a key role of ENG and MMP14 in cell mechano-transduction. Migration and adhesion assays confirmed that loss of ENG disrupts actin filament assembly and filopodia formation, with a concomitant effect on cell spreading. Furthermore, we observed that ENG regulates cell-matrix interaction through activation of focal adhesion signaling and protein kinase C expression. In turn, loss of MMP14 contributed to a more adhesive phenotype of ES cells by modulating the transcriptional extracellular matrix dynamics. Overall, these results suggest that ENG and MMP14 exert a significant role in mediating correct spreading machinery of ES cells, impacting the aggressiveness of the disease.


Asunto(s)
Neoplasias Óseas , Endoglina/metabolismo , Sarcoma de Ewing , Neoplasias Óseas/genética , Endoglina/genética , Humanos , Metaloproteinasa 14 de la Matriz/genética , Metaloproteinasa 14 de la Matriz/metabolismo , Proteómica , Receptores de Factores de Crecimiento , Sarcoma de Ewing/patología , Transducción de Señal
5.
Gastroenterology ; 159(2): 575-590, 2020 08.
Artículo en Inglés | MEDLINE | ID: mdl-32325086

RESUMEN

BACKGROUND & AIMS: Studies are needed to determine the mechanism by which Barrett's esophagus (BE) progresses to esophageal adenocarcinoma (EAC). Notch signaling maintains stem cells in the gastrointestinal tract and is dysregulated during carcinogenesis. We explored the relationship between Notch signaling and goblet cell maturation, a feature of BE, during EAC pathogenesis. METHODS: We measured goblet cell density and levels of Notch messenger RNAs in BE tissues from 164 patients, with and without dysplasia or EAC, enrolled in a multicenter study. We analyzed the effects of conditional expression of an activated form of NOTCH2 (pL2.Lgr5.N2IC), conditional deletion of NOTCH2 (pL2.Lgr5.N2fl/fl), or loss of nuclear factor κB (NF-κB) (pL2.Lgr5.p65fl/fl), in Lgr5+ (progenitor) cells in L2-IL1B mice (which overexpress interleukin 1 beta in esophagus and squamous forestomach and are used as a model of BE). We collected esophageal and stomach tissues and performed histology, immunohistochemistry, flow cytometry, transcriptome, and real-time polymerase chain reaction analyses. Cardia and forestomach tissues from mice were cultured as organoids and incubated with inhibitors of Notch or NF-kB. RESULTS: Progression of BE to EAC was associated with a significant reduction in goblet cell density comparing nondysplastic regions of tissues from patients; there was an inverse correlation between goblet cell density and levels of NOTCH3 and JAG2 messenger RNA. In mice, expression of the activated intracellular form of NOTCH2 in Lgr5+ cells reduced goblet-like cell maturation, increased crypt fission, and accelerated the development of tumors in the squamocolumnar junction. Mice with deletion of NOTCH2 from Lgr5+ cells had increased maturation of goblet-like cells, reduced crypt fission, and developed fewer tumors. Esophageal tissues from in pL2.Lgr5.N2IC mice had increased levels of RelA (which encodes the p65 unit of NF-κB) compared to tissues from L2-IL1B mice, and we found evidence of increased NF-κB activity in Lgr5+ cells. Esophageal tissues from pL2.Lgr5.p65fl/fl mice had lower inflammation and metaplasia scores than pL2.Lgr5.N2IC mice. In organoids derived from pL2-IL1B mice, the NF-κB inhibitor JSH-23 reduced cell survival and proliferation. CONCLUSIONS: Notch signaling contributes to activation of NF-κB and regulates differentiation of gastric cardia progenitor cells in a mouse model of BE. In human esophageal tissues, progression of BE to EAC was associated with reduced goblet cell density and increased levels of Notch expression. Strategies to block this pathway might be developed to prevent EAC in patients with BE.


Asunto(s)
Adenocarcinoma/patología , Esófago de Barrett/patología , Carcinogénesis/patología , Neoplasias Esofágicas/patología , Células Caliciformes/patología , Receptores Notch/metabolismo , Adenocarcinoma/diagnóstico , Adenocarcinoma/genética , Anciano , Animales , Esófago de Barrett/diagnóstico , Esófago de Barrett/genética , Biopsia , Carcinogénesis/genética , Diferenciación Celular/genética , Estudios Transversales , Modelos Animales de Enfermedad , Progresión de la Enfermedad , Mucosa Esofágica/citología , Mucosa Esofágica/diagnóstico por imagen , Mucosa Esofágica/patología , Neoplasias Esofágicas/diagnóstico , Neoplasias Esofágicas/genética , Esofagoscopía , Femenino , Mucosa Gástrica/citología , Mucosa Gástrica/patología , Humanos , Masculino , Ratones , Ratones Transgénicos , Persona de Mediana Edad , FN-kappa B/metabolismo , Estudios Prospectivos , ARN Mensajero/análisis , ARN Mensajero/metabolismo , Receptores Notch/genética , Transducción de Señal
6.
J Hum Genet ; 65(2): 165-174, 2020 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-31772335

RESUMEN

Somatic mutational mosaicism is a common feature of monogenic genetic disorders, particularly in diseases such as retinoblastoma, with high rates of de novo mutations. The detection and quantification of mosaicism is particularly relevant in these diseases, since it has important implications for genetic counseling, patient management, and probably also on disease onset and progression. In order to assess the rate of somatic mosaicism (high- and low-level mosaicism) in sporadic retinoblastoma patients, we analyzed a cohort of 153 patients with sporadic retinoblastoma using ultra deep next-generation sequencing. High-level mosaicism was detected in 14 out of 100 (14%) bilateral patients and in 11 out of 29 (38%) unilateral patients in whom conventional Sanger sequencing identified a pathogenic mutation in blood DNA. In addition, low-level mosaicism was detected in 3 out of 16 (19%) unilateral patients in whom conventional screening was negative in blood DNA. Our results also reveal that mosaicism was associated to delayed retinoblastoma onset particularly in unilateral patients. Finally we compared the level of mosaicism in different tissues to identify the best DNA source to identify mosaicism in retinoblastoma patients. In light of these results we recommended analyzing the mosaic status in all retinoblastoma patients using accurate techniques such as next-generation sequencing, even in those cases in which conventional Sanger sequencing identified a pathogenic mutation in blood DNA. Our results suggest that a significant proportion of those cases are truly mosaics that could have been overlooked. This information should be taking into consideration in the management and genetic counseling of retinoblastoma patients and families.


Asunto(s)
Mosaicismo , Retinoblastoma/genética , Estudios de Cohortes , Asesoramiento Genético , Genotipo , Secuenciación de Nucleótidos de Alto Rendimiento , Humanos , Mutación , Fenotipo , Sensibilidad y Especificidad , Análisis de Secuencia de ADN
7.
Molecules ; 25(6)2020 Mar 11.
Artículo en Inglés | MEDLINE | ID: mdl-32168823

RESUMEN

Removal of heavy metals from wastewater is mandatory in order to avoid water pollution of natural reservoirs. In the present study, layered double hydroxide (LDH) materials were evaluated for removal of zinc from aqueous solutions. Materials thus prepared were impregnated with cyanex 272 using the dry method. These materials were characterized through X-ray diffraction (XRD), Fourier transform infrared (FTIR), and thermal analysis. Batch shaking adsorption experiments were performed in order to examine contact time and extraction capacity in the removal process. Results showed that the equilibrium time of Zn (II) extraction is about 4 h for Mg2Al-CO3 and Mg2Al-CO3-cyanex 272, 6 h for Zn2Al-CO3, and 24 h for Zn2Al-CO3-cyanex 272. The experimental equilibrium data were tested for Langmuir, and Freundlich isotherm models. Correlation coefficients indicate that experimental results are in a good agreement with Langmuir's model for zinc ions. Pseudo-first, second-order, Elovich, and intraparticular kinetic models were used to describe kinetic data. It was determined that removal of Zn2+ was well-fitted by a second-order reaction kinetic. A maximum capacity of 280 mg/g was obtained by Zn2Al-CO3-cyanex 272.


Asunto(s)
Hidróxidos/química , Ácidos Fosfínicos/química , Contaminantes Químicos del Agua/aislamiento & purificación , Purificación del Agua/métodos , Zinc/aislamiento & purificación , Adsorción , Humanos , Cinética , Modelos Estadísticos , Aguas Residuales/química
8.
Am J Transplant ; 19(6): 1798-1805, 2019 06.
Artículo en Inglés | MEDLINE | ID: mdl-30586230

RESUMEN

We report data obtained from a retrospective multicenter pediatric survey on behalf of the European Society for Blood and Marrow Transplantation (EBMT). Information on solid organ transplantation (SOT) performed in pediatric recipients of either autologous or allogeneic hematopoietic stem cell transplantation (HSCT) between 1984 and 2016 was collected in 20 pediatric EBMT Centers (25.6%). Overall, we evaluated data on 44 SOTs following HSCT including 20 liver (LTx), 12 lung (LuTx), 6 heart (HTx), and 6 kidney (KTx) transplantations. The indication for SOT was organ failure related to intractable graft-vs-host disease in 16 children (36.3%), acute or chronic HSCT-related toxicity in 18 (40.9%), and organ dysfunction related to the underlying disease in 10 (22.8%). The median follow-up was 10.9 years (95% confidence interval: 1.7-29.5). The overall survival rate at 1 and 5 years after SOT was 85.7% and 80.4%, respectively: it was 74% and 63.2% after LTx, 83.2% after HTx, and 100% equally after LuTx and KTx. This multicenter survey confirms that SOT represents a promising option in children with severe organ failure occurring after HSCT. Additional studies are needed to further establish the effectiveness of SOT after HSCT and to better understand the mechanism underlying this encouraging success.


Asunto(s)
Enfermedad Injerto contra Huésped/etiología , Enfermedad Injerto contra Huésped/cirugía , Trasplante de Células Madre Hematopoyéticas/efectos adversos , Trasplante de Órganos , Adolescente , Aloinjertos , Autoinjertos , Niño , Preescolar , Estudios de Cohortes , Europa (Continente)/epidemiología , Femenino , Trasplante de Corazón , Humanos , Lactante , Trasplante de Riñón , Trasplante de Hígado , Trasplante de Pulmón , Masculino , Trasplante de Órganos/efectos adversos , Trasplante de Órganos/mortalidad , Modelos de Riesgos Proporcionales , Estudios Retrospectivos , Encuestas y Cuestionarios , Tasa de Supervivencia , Resultado del Tratamiento
10.
Pancreatology ; 19(4): 541-547, 2019 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-31109903

RESUMEN

OBJECTIVES: The importance of the Calcitonin-gene-related-peptide-pathway (CGRP) as neuronal modulator of innate immune responses in mice has been previously demonstrated. The CGRP-receptor is composed of two subunits: the receptor-activity-modifying-protein-1 (RAMP1) and the calcitonin-receptor-like-receptor (CLR). CGRP can influence immune cells and their capacity of producing inflammatory cytokines. Using a RAMP1 knockout-mouse (RAMP1-/-) we examined the role of the CGRP-receptor in the acute-phase of cerulein-induced pancreatitis. METHODS: Hourly cerulein-injections for a period of 8 h in RAMP1-/- and wild-type mice were performed. To compare severity and extent of inflammation in RAMP1-/- and wild-type mice, histological analyses were done and cytokine levels were assessed using qRT-PCR 8 h, 24 h, 2 days, and 7 days post-cerulein-treatment. Furthermore, serum activities of LDH and lipase were determined. RESULTS: After 8 h RAMP1-/- mice showed a higher pancreas-to-body-weight-ratio, increased tissue edema and immune cell infiltration with higher amount of F4/80-positive cells as compared to wild-type mice. Overall infiltration of immune cells at 24 h was increased in RAMP1-/- mice and composed predominantly of MPO-positive neutrophils. In addition, after 24 h RAMP1-/- mice presented a higher pancreas-to-body-weight-ratio, higher expression of Ccl3, Il6, and Il1b and increased number of cleaved caspase 3 positive cells. Serum lipase correlated with the extent of tissue damage in RAMP1-/- compared to wild-type mice 24 h post-cerulein treatment. CONCLUSION: Mice lacking RAMP1 showed increased inflammation, tissue edema, and pancreas injury particularly in the early phase of acute pancreatitis. This study highlights the essential role of CGRP for dampening the innate immune response in acute pancreatitis.


Asunto(s)
Inmunidad Innata/genética , Pancreatitis/genética , Pancreatitis/inmunología , Proteína 1 Modificadora de la Actividad de Receptores/genética , Enfermedad Aguda , Animales , Ceruletida , Citocinas/sangre , Femenino , Inflamación/inducido químicamente , Inflamación/patología , L-Lactato Deshidrogenasa/metabolismo , Lipasa/análisis , Lipasa/metabolismo , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Infiltración Neutrófila , Tamaño de los Órganos , Pancreatitis/inducido químicamente , Proteína 1 Modificadora de la Actividad de Receptores/inmunología
11.
Biol Blood Marrow Transplant ; 24(11): 2316-2323, 2018 11.
Artículo en Inglés | MEDLINE | ID: mdl-30031939

RESUMEN

The CD45RA T cell depletion (TCD) method has been used to deplete naive T cells, preventing graft-versus-host disease (GVHD) but preserving memory cells, providing immediate functional T cells with anti-infection, antileukemia, and antirejection effects. We describe a series of 25 consecutive high-risk patients with leukemia who received haploidentical hematopoietic stem cell transplantation (haplo-HSCT) with CD45RA TCD. Each patient received 2 cell products: 1 created by CD34 positive selection and the other through CD45RA depletion from the CD34 negative fraction by a CliniMACS device. CD45RA-depleted haplo-HSCT was well tolerated, with rapid engraftment and low risk of severe acute GVHD and chronic GVHD. Although this treatment achieved a good control of viral reactivations, such as cytomegalovirus and adenovirus, we observed an unexpectedly high rate of limbic encephalitis due to human herpesvirus-6 (HHV-6; 8 cases). Characteristically, the infection appeared early in almost all patients, just after the engraftment. Although no patient died from encephalitis, 1 patient showed neuropsychological sequelae, and another experienced secondary graft failure just after the HHV-6 reactivation.


Asunto(s)
Encefalitis Viral/etiología , Herpesvirus Humano 6/patogenicidad , Linfocitos T/metabolismo , Acondicionamiento Pretrasplante/métodos , Adolescente , Niño , Preescolar , Encefalitis Viral/patología , Femenino , Trasplante de Células Madre Hematopoyéticas/métodos , Humanos , Incidencia , Masculino
12.
Pharmacogenomics J ; 18(6): 704-712, 2018 12.
Artículo en Inglés | MEDLINE | ID: mdl-29282364

RESUMEN

Vincristine (VCR), an important component of childhood acute lymphoblastic leukemia (ALL) therapy, can cause sensory and motor neurotoxicity. This neurotoxicity could lead to dose reduction or treatment discontinuation, which could in turn reduce survival. In this line, several studies associated peripheral neurotoxicity and polymorphisms in genes involved in pharmacokinetics (PK) and pharmacodynamics (PD) of VCR. Nowadays, it is well known that these genes are regulated by microRNAs (miRNAs) and SNPs in miRNAs could modify their levels or function. Therefore, the aim of this study was to determine whether SNPs in miRNAs could be associated with VCR-induced neurotoxicity. To achieve this aim, we analyzed all the SNPs in miRNAs (minor allele frequency (MAF) ≥ 0.01) which could regulate VCR-related genes in a large cohort of Spanish children with B-cell precursor ALL (B-ALL) homogeneously treated with LAL/SHOP protocols. We identified the A allele of rs12402181 in the seed region of miR-3117-3p, that could affect the binding with ABCC1 and RALBP1 gene, and C allele of rs7896283 in pre-mature sequence of miR-4481, which could be involved in peripheral nerve regeneration, significantly associated with VCR-induced neurotoxicity. These findings point out the possible involvement of two SNPs in miRNA associated with VCR-related neurotoxicity.


Asunto(s)
Antineoplásicos Fitogénicos/efectos adversos , MicroARNs/genética , Enfermedad de la Neurona Motora/inducido químicamente , Enfermedad de la Neurona Motora/genética , Variantes Farmacogenómicas , Polimorfismo de Nucleótido Simple , Leucemia-Linfoma Linfoblástico de Células Precursoras B/tratamiento farmacológico , Trastornos de la Sensación/inducido químicamente , Trastornos de la Sensación/genética , Vincristina/efectos adversos , Transportadoras de Casetes de Unión a ATP/genética , Edad de Inicio , Antineoplásicos Fitogénicos/administración & dosificación , Niño , Preescolar , Femenino , Proteínas Activadoras de GTPasa/genética , Frecuencia de los Genes , Predisposición Genética a la Enfermedad , Humanos , Lactante , Masculino , Enfermedad de la Neurona Motora/diagnóstico , Proteínas Asociadas a Resistencia a Múltiples Medicamentos/genética , Farmacogenética , Pruebas de Farmacogenómica , Fenotipo , Leucemia-Linfoma Linfoblástico de Células Precursoras B/diagnóstico , Valor Predictivo de las Pruebas , Estudios Retrospectivos , Medición de Riesgo , Factores de Riesgo , Trastornos de la Sensación/diagnóstico , España , Vincristina/administración & dosificación
13.
Water Sci Technol ; 78(12): 2489-2499, 2018 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-30767914

RESUMEN

In this work, the mathematical modeling of the facilitated transport of germanium (non-dispersive extraction) through a flat sheet membrane with an Aliquat 336 carrier was described. The flat sheet supported liquid membrane (FSSLM) experiments were performed under conditions germanium ≈ 100 mg/L, tartaric acid concentration of 2.76 mmol/L, and carrier concentrations of 2.5-10%v/v. The extraction equilibrium, mass transfer, and diffusion equations based on Fick's law were the principles of modeling. Modeling was carried out by programming in Matlab mathematical software to obtain the extraction (Kex) and mass transfer constants (Km) as the objective parameters. According to the model resolution, Kex and Km were found to be 0.178 and 9.25 × 10-2 cm/s, respectively. The correlation coefficients between model and experimental data relating to the Aliquat 336 concentrations of 2.5, 5, 7.5, and 10%v/v were found as 0.96, 0.98, 0.99, and 0.92. The parameters of root mean square error, bias, and scatter index showed the model accuracy. In addition, diffusion coefficients relating to Aliquat 336 concentrations of 2.5, 5, 7.5, and 10%v/v were calculated using mass transfer coefficients to be 2.4 × 10-4, 2.23 × 10-4, 1.91 × 10-4, and 1.79 × 10-4 cm2/s, respectively.


Asunto(s)
Germanio/química , Modelos Químicos , Compuestos de Amonio Cuaternario/química , Contaminantes Químicos del Agua/química , Difusión , Modelos Teóricos , Agua
14.
Am J Pathol ; 186(11): 2934-2944, 2016 11.
Artículo en Inglés | MEDLINE | ID: mdl-27639167

RESUMEN

Perturbation of pancreatic acinar cell state can lead to acinar-to-ductal metaplasia (ADM), a precursor lesion to the development of pancreatic ductal adenocarcinoma (PDAC). In the pancreas, Notch signaling is active both during development and in adult cellular differentiation processes. Hes1, a key downstream target of the Notch signaling pathway, is expressed in the centroacinar compartment of the adult pancreas as well as in both preneoplastic and malignant lesions. In this study, we used a murine genetic in vivo approach to ablate Hes1 in pancreatic progenitor cells (Ptf1a+/Cre; Hes1fl/fl). Using this model, we studied the role of Hes1 in both acinar cell plasticity and pancreatic regeneration after caerulein-induced pancreatitis and in KrasG12D-driven PDAC development. We show that, although pancreatic development is not perturbed on the deletion of Hes1, terminal acinar differentiation in the adult pancreas is compromised. Moreover, the loss of Hes1 leads to the impaired regeneration of the exocrine compartment, accelerated fatty metaplasia, and persistent ADM after acute caerulein-induced pancreatitis. In KrasG12D-driven carcinogenesis, Hes1 ablation resulted in increased ADM, decreased formation of high-grade pancreatic intraepithelial neoplasias, and accelerated development of PDAC with shortened survival time. In conclusion, Hes1 plays a key role in acinar cell integrity and plasticity on cellular insults. Furthermore, Hes1 is an essential component of the pancreatic intraepithelial neoplasias-to-PDAC route in KrasG12D-driven mouse pancreatic carcinogenesis.


Asunto(s)
Carcinoma Ductal Pancreático/etiología , Neoplasias Pancreáticas/etiología , Transducción de Señal , Factor de Transcripción HES-1/metabolismo , Células Acinares/patología , Células Acinares/fisiología , Animales , Carcinogénesis , Carcinoma Ductal Pancreático/genética , Carcinoma Ductal Pancreático/patología , Diferenciación Celular , Plasticidad de la Célula , Ceruletida/efectos adversos , Modelos Animales de Enfermedad , Femenino , Humanos , Masculino , Metaplasia , Ratones , Páncreas/patología , Páncreas/fisiología , Páncreas Exocrino/patología , Páncreas Exocrino/fisiología , Neoplasias Pancreáticas/genética , Neoplasias Pancreáticas/patología , Pancreatitis/inducido químicamente , Pancreatitis/patología , Regeneración , Células Madre/patología , Células Madre/fisiología , Factor de Transcripción HES-1/genética
15.
Pancreatology ; 17(3): 350-353, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28473229

RESUMEN

OBJECTIVES: Pancreatic ductal adenocarcinoma (PDAC) is thought to derive from different precursor lesions including the recently identified atypical flat lesions (AFL). While all precursor lesions and PDAC share ductal characteristics, there is an ongoing debate about the cellular origin of the different PDAC precursor lesions. In particular, pancreatic acinar cells have previously been shown to display a remarkable plasticity being able to undergo ductal dedifferentiation in the context of oncogenic stimuli. METHODS: Histological analyses were performed in a murine PDAC model that specifically expresses oncogenic Kras in adult pancreatic acinar cells. Occurrence, characterization, and lineage tracing of AFLs were investigated. RESULTS: Upon expression of oncogenic Kras in adult pancreatic acinar cells, AFLs with typical morphology and expression profile arise. Lineage tracing confirmed that the AFLs were of acinar origin. CONCLUSIONS: Using a murine PDAC model, this study identifies pancreatic acinar cells as a cellular source for AFLs.


Asunto(s)
Células Acinares/patología , Carcinoma Ductal Pancreático/patología , Neoplasias Pancreáticas/patología , Animales , Carcinoma Ductal Pancreático/inducido químicamente , Carcinoma Ductal Pancreático/metabolismo , Diferenciación Celular , Transformación Celular Neoplásica/patología , Antagonistas de Estrógenos , Inmunohistoquímica , Ratones , Neoplasias Pancreáticas/inducido químicamente , Neoplasias Pancreáticas/metabolismo , Proteínas Proto-Oncogénicas p21(ras)/biosíntesis , Proteínas Proto-Oncogénicas p21(ras)/genética , Tamoxifeno
16.
Pharmacogenet Genomics ; 26(11): 517-525, 2016 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-27649261

RESUMEN

OBJECTIVES: Methotrexate (MTX), the key drug in childhood B-cell acute lymphoblastic leukemia (B-ALL) therapy, often causes toxicity. An association between genetic variants in MTX transport genes and toxicity has been found. It is known that these transporters are regulated by microRNAs (miRNAs), and miRNA single nucleotide polymorphisms (SNPs) interfere with miRNA levels or function. With regard to B-cell ALL, we have previously found rs56103835 in miR-323b that targets ABCC4 associated with MTX plasma levels. Despite these evidences and that nowadays a large amount of new miRNAs have been annotated, studies of miRNA polymorphisms and MTX toxicity are almost absent. Therefore, the aim of this study was to determine whether there are other variants in miRNAs associated with MTX levels. PATIENTS AND METHODS: Blood samples of 167 Spanish patients with pediatric B-cell ALL treated with the LAL-SHOP protocol were analyzed. We selected all the SNPs described in pre-miRNAs with a minor allele frequency more than 1% (213 SNPs in 206 miRNAs) that could regulate MTX transporters because the miRNAs that target MTX transporter genes are not completely defined. Genotyping was performed with VeraCode GoldenGate platform. RESULTS: Among the most significant results, we found rs56292801 in miR-5189, rs4909237 in miR-595, and rs78790512 in miR-6083 to be associated with MTX plasma levels. These miRNAs were predicted, in silico, to regulate genes involved in MTX uptake: SLC46A1, SLC19A1, and SLCO1A2. CONCLUSION: In this study, we detected three SNPs in miR-5189, miR-595, and miR-6083 that might affect SLC46A1, SLC19A1, and SLCO1A2 MTX transport gene regulation and could affect MTX levels in patients with pediatric B-cell ALL.


Asunto(s)
Antimetabolitos Antineoplásicos/efectos adversos , Metotrexato/efectos adversos , MicroARNs/genética , Polimorfismo de Nucleótido Simple , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamiento farmacológico , Antimetabolitos Antineoplásicos/uso terapéutico , Niño , Preescolar , Femenino , Humanos , Masculino , Metotrexato/uso terapéutico , Transportadores de Anión Orgánico/genética , Transportador de Folato Acoplado a Protón/genética , Proteína Portadora de Folato Reducido/genética , Estudios Retrospectivos , España , Población Blanca/genética
17.
Development ; 139(23): 4405-15, 2012 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-23132247

RESUMEN

Notch and Wnt are highly conserved signalling pathways that are used repeatedly throughout animal development to generate a diverse array of cell types. However, they often have opposing effects on cell-fate decisions with each pathway promoting an alternate outcome. Commonly, a cell receiving both signals exhibits only Wnt pathway activity. This suggests that Wnt inhibits Notch activity to promote a Wnt-ON/Notch-OFF output; but what might underpin this Notch regulation is not understood. Here, we show that Wnt acts via Dishevelled to inhibit Notch signalling, and that this crosstalk regulates cell-fate specification in vivo during Xenopus development. Mechanistically, Dishevelled binds and directly inhibits CSL transcription factors downstream of Notch receptors, reducing their activity. Furthermore, our data suggest that this crosstalk mechanism is conserved between vertebrate and invertebrate homologues. Thus, we identify a dual function for Dishevelled as an inhibitor of Notch signalling and an activator of the Wnt pathway that sharpens the distinction between opposing Wnt and Notch responses, allowing for robust cell-fate decisions.


Asunto(s)
Proteínas Adaptadoras Transductoras de Señales/metabolismo , Proteína de Unión a la Señal Recombinante J de las Inmunoglobulinas/metabolismo , Fosfoproteínas/metabolismo , Receptores Notch/metabolismo , Proteínas Wnt/metabolismo , Proteínas de Xenopus/metabolismo , Xenopus/embriología , Animales , Células CHO , Línea Celular , Cricetinae , Proteínas Dishevelled , Epidermis/embriología , Células HEK293 , Humanos , Proteína de Unión a la Señal Recombinante J de las Inmunoglobulinas/antagonistas & inhibidores , Receptores Notch/antagonistas & inhibidores , Vía de Señalización Wnt , Proteínas de Xenopus/antagonistas & inhibidores
18.
Cell Mol Life Sci ; 71(18): 3553-67, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-24942883

RESUMEN

The Notch and Wnt pathways are two of only a handful of highly conserved signalling pathways that control cell-fate decisions during animal development (Pires-daSilva and Sommer in Nat Rev Genet 4: 39-49, 2003). These two pathways are required together to regulate many aspects of metazoan development, ranging from germ layer patterning in sea urchins (Peter and Davidson in Nature 474: 635-639, 2011) to the formation and patterning of the fly wing (Axelrod et al in Science 271:1826-1832, 1996; Micchelli et al in Development 124:1485-1495, 1997; Rulifson et al in Nature 384:72-74, 1996), the spacing of the ciliated cells in the epidermis of frog embryos (Collu et al in Development 139:4405-4415, 2012) and the maintenance and turnover of the skin, gut lining and mammary gland in mammals (Clayton et al in Nature 446:185-189, 2007; Clevers in Cell 154:274-284, 2013; Doupe et al in Dev Cell 18:317-323, 2010; Lim et al in Science 342:1226-1230, 2013; Lowell et al in Curr Biol 10:491-500, 2000; van et al in Nature 435:959-963, 2005; Yin et al in Nat Methods 11:106-112, 2013). In addition, many diseases, including several cancers, are caused by aberrant signalling through the two pathways (Bolós et al in Endocr Rev 28: 339-363, 2007; Clevers in Cell 127: 469-480, 2006). In this review, we will outline the two signalling pathways, describe the different points of interaction between them, and cover how these interactions influence development and disease.


Asunto(s)
Modelos Biológicos , Receptores Notch/fisiología , Vía de Señalización Wnt , Animales , Linaje de la Célula , Drosophila/crecimiento & desarrollo , Drosophila/metabolismo , Regulación de la Expresión Génica , Redes Reguladoras de Genes , Mamíferos/crecimiento & desarrollo , Mamíferos/metabolismo , Receptores Notch/metabolismo , Transducción de Señal
19.
J Chem Technol Biotechnol ; 89(6): 934-940, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25821332

RESUMEN

BACKGROUND: A column sorption study was carried out using calcium alginate gel beads as adsorbent for the removal of boron from aqueous solutions. The breakthrough curve was obtained as a function of pH, initial concentration of boron, feed flow rate, adsorbent mass and column diameter. The breakthrough capacity values and adsorption percentage of calcium alginate gel for boron were calculated. Column data obtained at different conditions were described using the Adams-Bohart model and bed-depth service time (BDST), derived from the Adams-Bohart equation to predict breakthrough curves and to determine the characteristic column parameters required for process design. RESULTS: The maximum adsorption percentage of boron on calcium alginate gel beads using an initial concentration of boron of 50 mg L-1 at pH 11 and room temperature (20±1°C) was calculated to be 55.14%. CONCLUSION: The results indicated that calcium alginate can be used in a continuous packed-bed column for boron adsorption. The optimal conditions for boron adsorption were obtained at high pH, higher initial boron concentration, increased column depth and lower flow velocity. © 2014 The Authors. Journal of Chemical Technology & Biotechnology published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.

20.
Sci Rep ; 14(1): 12129, 2024 05 27.
Artículo en Inglés | MEDLINE | ID: mdl-38802399

RESUMEN

Many targeted cancer therapies rely on biomarkers assessed by scoring of immunohistochemically (IHC)-stained tissue, which is subjective, semiquantitative, and does not account for expression heterogeneity. We describe an image analysis-based method for quantitative continuous scoring (QCS) of digital whole-slide images acquired from baseline human epidermal growth factor receptor 2 (HER2) IHC-stained breast cancer tissue. Candidate signatures for patient stratification using QCS of HER2 expression on subcellular compartments were identified, addressing the spatial distribution of tumor cells and tumor-infiltrating lymphocytes. Using data from trastuzumab deruxtecan-treated patients with HER2-positive and HER2-negative breast cancer from a phase 1 study (NCT02564900; DS8201-A-J101; N = 151), QCS-based patient stratification showed longer progression-free survival (14.8 vs 8.6 months) with higher prevalence of patient selection (76.4 vs 56.9%) and a better cross-validated log-rank p value (0.026 vs 0.26) than manual scoring based on the American Society of Clinical Oncology / College of American Pathologists guidelines. QCS-based features enriched the HER2-negative subgroup by correctly predicting 20 of 26 responders.


Asunto(s)
Neoplasias de la Mama , Selección de Paciente , Receptor ErbB-2 , Trastuzumab , Humanos , Femenino , Receptor ErbB-2/metabolismo , Neoplasias de la Mama/tratamiento farmacológico , Neoplasias de la Mama/metabolismo , Neoplasias de la Mama/patología , Trastuzumab/uso terapéutico , Persona de Mediana Edad , Biomarcadores de Tumor/metabolismo , Adulto , Inmunoconjugados/uso terapéutico , Antineoplásicos Inmunológicos/uso terapéutico , Anciano , Inmunohistoquímica , Camptotecina/análogos & derivados
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA